6 Einträge gefunden

1. Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy

   1. Michl, Uwe
   2. Molfenter, Frederike
   3. Graefen, Markus
   4. Tennstedt, Pierre
   5. Ahyai, Sascha
   6. Beyer, Burkhard
   7. Budäus, Lars

   2015 - Forschungsinformationssystem des UKE
2. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level

   1. Ahyai, Sascha
   2. Graefen, Markus
   3. Steuber, Thomas
   4. Haese, Alexander
   5. Schlomm, Thorsten
   6. Walz, Jochen
   7. Köllermann, Jens

   2008 - Forschungsinformationssystem des UKE
3. Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.

   1. Capitanio, Umberto
   2. Ahyai, Sascha
   3. Graefen, Markus
   4. Jeldres, Claudio
   5. Shariat, Shahrokh F
   6. Erbersdobler, Andreas
   7. Schlomm, Thorsten

   2008 - Forschungsinformationssystem des UKE
4. Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.

   1. Jeldres, Claudio
   2. Suardi, Nazareno
   3. Walz, Jochen
   4. Hutterer, Georg C
   5. Ahyai, Sascha
   6. Lattouf, Jean-Baptiste
   7. Haese, Alexander

   2008 - Forschungsinformationssystem des UKE
5. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

   1. Chun, Felix
   2. Haese, Alexander
   3. Ahyai, Sascha
   4. Walz, Jochen
   5. Nazareno, Suardi
   6. Capitanio, Umberto
   7. Graefen, Markus

   2008 - Forschungsinformationssystem des UKE
6. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

   1. Chun, Felix
   2. Suardi, Nazareno
   3. Capitanio, Umberto
   4. Jeldres, Claudio
   5. Ahyai, Sascha
   6. Graefen, Markus
   7. Haese, Alexander

   2008 - Forschungsinformationssystem des UKE